StonvexLoading…
StonvexCore line items from YB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | ¥4.37B | ¥3.28B | ¥2.05B |
Operating Income | ¥1.41B | ¥891.41M | ¥205.48M |
Net Income | ¥1.31B | ¥865.85M | ¥203.12M |
EPS (Diluted) | ¥4.57 | ¥3.19 | ¥-4.71 |
Total Assets | ¥4.66B | ¥2.78B | Not available |
Total Liabilities | ¥1.31B | ¥992.55M | Not available |
Cash & Equivalents | ¥860.46M | ¥1.90B | ¥863.12M |
Free Cash Flow OCF − CapEx | ¥1.48B | ¥1.20B | ¥437.33M |
Shares Outstanding | 285.90M | 106.99M | 70.71M |